Learn languages naturally with fresh, real content!

Popular Topics
Explore By Region
New drug baxdrostat shows promise in reducing blood pressure and kidney risks in kidney disease patients.
A new drug, baxdrostat, shows promise in lowering high blood pressure in patients with chronic kidney disease.
The Phase 2 trial found it reduced systolic blood pressure by 5% and decreased a kidney risk marker by 55%.
While effective, it caused high potassium levels in some patients.
The drug's success could improve long-term health outcomes for those with uncontrolled blood pressure and kidney disease.
3 Articles
El nuevo fármaco baxdrostat se muestra prometedor para reducir la presión arterial y los riesgos renales en pacientes con enfermedad renal.